SCHEMBL4333690

SCHEMBL4333690

C=C(Cc1ccc(-n2ccnn2)cc1)C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 10/20 0.45
CYP19A1 P11511 1/20 0.40
MAPK9 P45984 1/20 0.38
MAPK10 P53779 1/20 0.38
BRS3 P32247 1/20 0.36
QPCT Q16769 1/20 0.36
KEAP1 Q14145 1/20 0.35
POLB P06746 2/20 0.33
NSD2 O96028 1/20 0.33
GRK2 P25098 1/20 0.33
CASP6 P55212 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
BLM P54132 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGA2B P08514 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9969614 0.85 NOTUM (0.54) NOTUMCYP19A1MAPK9MAPK10BRS3
SCHEMBL2658779 0.80 QPCT (0.56) NOTUMCYP19A1QPCTPOLBNSD2
SCHEMBL1124284 0.80 CA12 (0.46) NOTUM
SCHEMBL9969615 0.79 NOTUM (0.50) NOTUMCYP19A1MAPK9MAPK10BRS3
SCHEMBL6877497 0.74 NOTUM (0.60) NOTUMCYP19A1BRS3KEAP1
SCHEMBL4328741 0.74 SMN1; SMN2 (0.46) MAPK10BRS3QPCT
SCHEMBL6827358 0.73 NOTUM (0.55) NOTUMCYP19A1MAPK9MAPK10KEAP1
SCHEMBL4921031 0.73 NOTUM (0.58) NOTUMCYP19A1BRS3KEAP1
SCHEMBL533418 0.73 NOTUM (0.58) NOTUMCYP19A1BRS3KEAP1
SCHEMBL10447781 0.72 NOTUM (0.78) NOTUMCYP19A1BRS3KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009141782-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS ACTELION PHARMACEUTICALS LTD (CH) 2009-11-26 WO claimed
WO-2009141782-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS ACTELION PHARMACEUTICALS LTD (CH) 2009-11-26 WO disclosed